Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02404285 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne
A Phase 1 study, sponsored by Next Science TM.
- Completed
- Registry status
- Phase 1
- Development phase
- 68
- Enrollment target
NCT02404285 is a Phase 1 study that has completed, run by Next Science TM. The registered enrollment target is 68 participants.
The verdict
NCT02404285, a Phase 1 study, has completed, sponsored by Next Science TM.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 68 participants
- Enrollment target
Study Summary
This is a 12 week, multi-site, double-blind, vehicle-controlled study in subjects with mild to moderate facial acne. Subjects will be randomized 1:1 to apply either topical NAG or vehicle gel daily. Subjects will be evaluated for clinical acne and quality of life outcomes at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks.
Interventions
- DRUG Vehicle
- DRUG Next Science Acne Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02404285
The ClinicalTrials.gov registry entry for NCT02404285 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Next Science TM, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT02404285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02404285 about?
NCT02404285 is a clinical study titled "A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne". This is a 12 week, multi-site, double-blind, vehicle-controlled study in subjects with mild to moderate facial acne. Subjects will be randomized 1:1 to apply either topical NAG or vehicle gel daily. Subjects will be evaluated for clinical acne and quality of life outcomes at baseline, 2 weeks, 4 wee...
What is the current status of trial NCT02404285?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2015-03. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02404285?
The interventions under investigation include: Vehicle (DRUG), Next Science Acne Gel (DRUG).
Who is sponsoring clinical trial NCT02404285?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.